Medicamen Biotech Limited (BOM:531146)

Market Cap	4.48B
Revenue (ttm)	1.70B
Net Income (ttm)	90.53M
Shares Out	12.71M
EPS (ttm)	7.45
PE Ratio	47.33
Forward PE	n/a
Dividend	1.00 (0.27%)
Ex-Dividend Date	Sep 19, 2025

Volume	231
Average Volume	1,067
Open	360.60
Previous Close	364.60
Day's Range	353.80 - 360.60
52-Week Range	292.50 - 560.00
Beta	0.53
RSI	39.38
Earnings Date	Feb 10, 2026

About Medicamen Biotech

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi,...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 376
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531146

Financial Performance

In 2024, Medicamen Biotech's revenue was 1.68 billion, a decrease of -6.56% compared to the previous year's 1.79 billion. Earnings were 71.08 million, a decrease of -34.97%.